THALIDOMIDE IN LEPROSY

被引：0
作者：
BERKELEY, JS
机构：
来源：
BRITISH MEDICAL JOURNAL | 1968年 / 3卷 / 5609期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：42 / &
相关论文
共 50 条
  • [41] Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day
    de Mello Ayres Putinatti, Maria Stella
    Lastoria, Joel Carlos
    Padovani, Carlos Roberto
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2014, 89 (02) : 266 - 272
  • [42] Notorious teratogen wins FDA approval for leprosy - Thalidomide will be most tightly regulated drug ever
    不详
    BIOTECHNOLOGY LAW REPORT, 1998, 17 (05): : 596 - 597
  • [43] Synthesis and evaluation of novel dapsone-thalidomide hybrids for the treatment of type 2 leprosy reactions
    Yamasaki, Paulo Renato
    do Nascimento, Dejair Caetano
    Chelucci, Rafael Consolin
    Fernandes Belone, Andrea de Faria
    Rosa, Patricia Sammarco
    Diorio, Suzana Madeira
    Ferreira de Melo, Thais Regina
    Barbieri, Karina Pereira
    Polesi Placeres, Marisa Campos
    Carlos, Iracilda Zepone
    Chung, Man Chin
    dos Santos, Jean Leandro
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (14) : 3084 - 3087
  • [44] SIGNIFICANCE OF NEUTROPHIL ACTIVATION IN REACTIONAL LEPROMATOUS LEPROSY - EFFECTS OF THALIDOMIDE INVIVO AND INVITRO - ACTIVATION IN ADJUVANT DISEASE
    GOIHMANYAHR, M
    CONVIT, J
    RODRIGUEZOCHOA, G
    ARANZAZU, N
    VILLALBAPIMENTEL, L
    OCANTO, A
    ELENADEGOMEZ, M
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1978, 57 (04): : 317 - 332
  • [45] Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy
    Sales, A. M.
    de Matos, H. J.
    Nery, J. A. C.
    Duppre, N. C.
    Sampaio, E. P.
    Sarno, E. N.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2007, 40 (02) : 243 - 248
  • [46] Recognition of the phenotype of thalidomide embryopathy in countries endemic for leprosy: new cases and review of the main dysmorphological findings
    Vianna, Fernanda S. L.
    Schueler-Faccini, Lavinia
    Leite, Julio Cesar L.
    de Sousa, Silvia H. C.
    da Costa, Lea Marcia M.
    Dias, Murilo F.
    Morelo, Elaine F.
    Doriqui, Maria Juliana R.
    Maximino, Claudia M.
    Sanseverino, Maria Teresa V.
    CLINICAL DYSMORPHOLOGY, 2013, 22 (02) : 59 - 63
  • [47] Mucormycosis and chromoblastomycosis occurring in a patient with leprosy type 2 reaction under prolonged corticosteroid and thalidomide therapy
    Alves Basilio, Flavia Machado
    Hammerschmidt, Mariana
    Mukai, Maira Mitsue
    Werner, Betina
    Pinheiro, Rosangela Lameira
    Moritz, Sandra
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2012, 87 (05) : 767 - 771
  • [48] Deep venous thrombosis and pulmonary embolism secondary to co-administration of thalidomide and oral corticosteroid in a patient with leprosy
    Yamaguchi, Sayaka
    Yamamoto, Yuichi
    Hosokawa, Atsushi
    Hagiwara, Keisuke
    Uezato, Hiroshi
    Takahashi, Kenzo
    JOURNAL OF DERMATOLOGY, 2012, 39 (08) : 711 - 714
  • [49] Immunomodulation by thalidomide and thalidomide analogues
    Corral, LG
    Kaplan, G
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 107 - 113
  • [50] Randomized control trial to evaluate the clinical and cytokine response profile to oral thalidomide in leprosy patients with erythema nodosum leprosum
    Mitra, B.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 457 - 457
12345